<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Invest</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Invest</journal-id>
<journal-id journal-id-type="publisher-id">J Clin Invest</journal-id>
<journal-title-group>
<journal-title>The Journal of Clinical Investigation</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9738</issn>
<issn pub-type="epub">1558-8238</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31483294</article-id>
<article-id pub-id-type="pmc">6763223</article-id>
<article-id pub-id-type="publisher-id">127032</article-id>
<article-id pub-id-type="doi">10.1172/JCI127032</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Brain somatic mutations in <italic>MTOR</italic> reveal translational dysregulations underlying intractable focal epilepsy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Jang Keun</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Jun</given-names>
</name>
<email>jun_cho@hms.harvard.edu</email>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7516-7372</contrib-id>
<name>
<surname>Kim</surname>
<given-names>Se Hoon</given-names>
</name>
<email>paxco@yuhs.ac.kr</email>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kang</surname>
<given-names>Hoon-Chul</given-names>
</name>
<email>hipo0207@yuhs.ac</email>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Dong-Seok</given-names>
</name>
<email>dskim33@yuhs.ac</email>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>V. Narry</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2299-630X</contrib-id>
<name>
<surname>Lee</surname>
<given-names>Jeong Ho</given-names>
</name>
<email>jhlee4246@kaist.ac.kr</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.</aff>
<aff id="A2"><label>2</label>Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.</aff>
<aff id="A3"><label>3</label>Center for RNA Research, Institute for Basic Science, Seoul, Republic of Korea.</aff>
<aff id="A4"><label>4</label>Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea.</aff>
<aff id="A5"><label>5</label>Division of Pediatric Neurology, Department of Pediatrics, Pediatric Epilepsy Clinics, Severance Children’s Hospital, Epilepsy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</aff>
<aff id="A6"><label>6</label>Epilepsy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</aff>
<aff id="A7"><label>7</label>Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Republic of Korea.</aff>
<aff id="A8"><label>8</label>Department of Biological Sciences, Seoul National University, Seoul, Republic of Korea.</aff>
<aff id="A9"><label>9</label>Graduate School of Medical Science and Engineering, KAIST, Daejeon, Republic of Korea.</aff>
<author-notes>
<corresp>Address correspondence to: Jeong Ho Lee, E7-7108, KAIST, Daejeon 34131, Republic of Korea. Phone: 82.10.8630.0173; Email: <email>jhlee4246@kaist.ac.kr</email>.</corresp>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> JHL is a cofounder and chief technology officer of SoVarGen Inc., which develops new diagnostics and therapeutics for brain disorders. SoVarGen Inc. plans to apply for patents on the basis of the results of the current study.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2019-09-04T16:00:00-0400" publication-format="electronic">
<day>4</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2019-09-04T16:00:00-0400" publication-format="electronic">
<day>4</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date date-type="pub" iso-8601-date="2019-10-01T16:00:00-0400" publication-format="print">
<day>1</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>1</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 3 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>129</volume>
<issue>10</issue>
<fpage>4207</fpage>
<lpage>4223</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>12</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>3</day>
<month>7</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 American Society for Clinical Investigation</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://www.jci.org/articles/view/127032">This article is available online at https://www.jci.org/articles/view/127032</self-uri>
<abstract>
<p>Brain somatic mutations confer genomic diversity in the human brain and cause neurodevelopmental disorders. Recently, brain somatic activating mutations in <italic>MTOR</italic> have been identified as a major etiology of intractable epilepsy in patients with cortical malformations. However, the molecular genetic mechanism of how brain somatic mutations in <italic>MTOR</italic> cause intractable epilepsy has remained elusive. In this study, translational profiling of intractable epilepsy mouse models with brain somatic mutations and genome-edited cells revealed a novel translational dysregulation mechanism and mTOR activation–sensitive targets mediated by human <italic>MTOR</italic> mutations that lead to intractable epilepsy with cortical malformation. These mTOR targets were found to be regulated by novel mTOR-responsive 5′-UTR motifs, distinct from known mTOR inhibition–sensitive targets regulated by 5′ terminal oligopyrimidine motifs. Novel mTOR target genes were validated in patient brain tissues, and the mTOR downstream effector eIF4E was identified as a new therapeutic target in intractable epilepsy via pharmacological or genetic inhibition. We show that metformin, an FDA-approved eIF4E inhibitor, suppresses intractable epilepsy. Altogether, the present study describes translational dysregulation resulting from brain somatic mutations in <italic>MTOR</italic>, as well as the pathogenesis and potential therapeutic targets of intractable epilepsy.</p>
</abstract>
<kwd-group kwd-group-type="specialties">
<kwd>Neuroscience</kwd>
<kwd>Therapeutics</kwd>
</kwd-group>
<kwd-group kwd-group-type="keywords">
<kwd>Epilepsy</kwd>
<kwd>Genetic variation</kwd>
<kwd>Translation</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>the Suh Kyungbae Foundation; Korean Health Technology R&amp;D Project, Ministry of Health &amp; Welfare</funding-source>
<award-id>H16C0415</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>